Skip to content

Follow us on Threads!
Our Bloggers
Google News
Substack
FaceBook
Contribute/Contact
Search

Harvard University

Person scratching their arm

Uncovering a culprit behind the itch: Staphylococcus aureus

Harvard University

Categories Health

coal burning

Study Exposes Coal’s Deadly Toll: 460K Deaths Revealed

Harvard University

Categories Earth, Energy & Environment

Artist’s concept of Kepler-385, the seven-planet system revealed in a new catalog of planet candidates discovered by NASA’s Kepler space telescope. Credit: Daniel Rutter/NASA. All Rights Reserved.

Many planets beyond our solar system follow nearly circular orbital paths

Harvard University

Categories Physics & Mathematics, Space

Young man watching tv in the dark

The rise of ‘incels’

Harvard University

Categories Social Sciences

Ground beef

Red meat consumption associated with increased type 2 diabetes risk

Harvard University

Categories Health

Heart illustration

Heart cells start beating suddenly and all at once

Harvard University

Categories Health

Illustration of a heart and stethoscope

Transfer of ageing: New drug class prevents key ageing mechanism in organ transplants

Harvard University

Categories Health

Researchers create ‘designer bacteria’ to target autoimmunity in the brain, making treatment safer and more effective

Engineered probiotic developed to treat multiple sclerosis

Harvard University

Categories Health

Neurons. Alzheimer’s disease varies widely in its age of onset, presentation, and severity. Recently, the SORL1 gene has received increased attention since variations in this gene have been associated with both early- and late-onset Alzheimer’s. However, little is known about how damage to SORL1 leads to disease. Using stem cells from patients with Alzheimer’s, investigators from Harvard-affiliated Brigham and Women’s Hospital found that loss of normal SORL1 function leads to a reduction in two key proteins known to be involved in Alzheimer’s and which play an essential role in the neurons of healthy individuals. Their results, published in Cell Reports, suggest a potential strategy for Alzheimer’s disease treatment, especially for patients not responsive to existing therapies. In this new study, the researchers utilized a stem-cell based approach that examined natural genetic variability in Alzheimer’s patients to gain insight into an alternative pathway driving disease. The researchers used CRISPR technologies to remove the SORL1 gene from progenitor stem cells, derived from participants in two Alzheimer’s research cohorts, the Religious Order Studies and Rush Memory and Aging Project. They then programmed the stem cells to differentiate into four different kinds of brain cells to examine the impact of removing SORL1 on each cell type. The most dramatic impact was seen in neurons and a “support” cell in the brain (astrocytes). Neurons lacking SORL1 demonstrated especially prominent reduction in the levels of two key Alzheimer’s disease proteins: APOE and CLU. Without APOE and CLU, neurons cannot properly regulate lipids, which accumulate in droplets that may impair neurons’ abilities to communicate with each other. The researchers verified their lab-based results by examining natural genetic variation in SORL1 expression in the brain tissue of 50 members of the cohorts, finding again that lower SORL1 activity in neurons was correlated with reduced APOE and CLU in these people. Historically, researchers have studied three potent genetic drivers of Alzheimer’s disease (APP, PSEN1 and PSEN2), which are commonly mutated in hereditary, early-onset Alzheimer’s (AD diagnosis before age 65). Preclinical models and cell-based systems largely rely on mutations in these genes to model Alzheimer’s disease, even though in many people with late-onset (“sporadic”) Alzheimer’s, a more complex interaction between genes, lifestyle, and environment determines the presentation of the disease. Key neurological features of Alzheimer’s disease, including the abundance of amyloid-beta plaques in the brain, also vary across individuals. “Our study is one of the first with human cells from a large collection of individuals to try to understand the ‘molecular road’ that starts with SORL1, which we now see converges with APOE,” said corresponding author Tracy Young-Pearse of the Ann Romney Center for Neurological Diseases. “Our research points to the importance of developing interventions that target these and other molecular roads to Alzheimer’s disease. The more we can understand subtype-specific differences in AD, the better we will be able to design rational therapeutic interventions to try to fix the problem that is primarily driving disease in each patient.” The researchers are continuing to study other pathways that may lead to Alzheimer’s disease, such as those involving microglia (brain cells that perform immune functions). By using study models and techniques reflective of Alzheimer’s disease presentation in the general population, the researchers hope to identify additional biological pathways important in Alzheimer’s disease. In addition, Brigham researchers have played a leadership role in understanding the molecular and genetic basis for Alzheimer’s disease, including making key discoveries related to the amyloid protein. Two novel anti-amyloid therapies, aducanumab and lecanemab, have received U.S. Food and Drug Administration accelerated and traditional approval, respectively, but not all patients respond to these drugs, warranting other treatment options. This work was supported by the National Institutes of Health (F31AG063399, U01AG072572, U01AG061356, RF1NS117446 and R01AG055909).

The road that ends with Alzheimer’s

Harvard University

Categories Brain & Behavior

Chemical analysis brings understudied microbiome into sharper focus

Vaginal bacteria must eat to survive — but how?

Harvard University

Categories Health

Snarling do. From Harvard PIO

As temps climb so do number of dog bites

Harvard University

Categories Brain & Behavior, Earth, Energy & Environment, Health, Life & Non-humans

Omega 3 molecules

Omega-3 Fatty Acids May Slow ALS Progression, Reduce Death Risk

Harvard University

Categories Health

Page1 Page2 … Page19 Next →

Bloggers

Disasters at sea trigger ship-safety advances
Fighting extreme weather with extreme computing power
Expected rise in fossil fuel use this decade could offset action to me…
A leader in the climate age: America’s ‘essential’ railroad network
High hopes: the quest to turn cannabis into a potent medicine
$16B NEC investment advances President Biden’s domestic world-class pa…

Archives

Archives

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

© 2023 ScienceBlog.com | Follow our RSS / XML feed